info iconCurrently, the share price for Dr. Reddy's Laboratories Ltd. is delayed.

close icon
Dr. Reddy's Laboratories Ltd. Logo

Dr. Reddy's Laboratories Ltd.

₹6,376.00
NSE
--   ( -- %) 1D



  • Prev. Close
    6,376.00
  • Upper Circuit
    7,013.60
  • Lower Circuit
    5,738.40

Analyst Recommendations For Dr. Reddy's Laboratories Ltd.

Info icon
As recommended by 10 analysts

Returns

Dr. Reddy's Laboratories Ltd.'s Info & Management

Dr. Reddy’s Laboratories is an Indian-origin multi-national company in the pharmaceutical sector. It is involved in the manufacturing and marketing of a wide catalogue of pharmaceuticals in the global market. The company was founded in 1984 and is headquartered in Hyderabad, India. 

Business Segment

The business segments include:

  • Pharmaceutical Services and Active Ingredients: primarily consists of the company’s business of manufacturing and marketing APIs and intermediates 
  • Global Generics: consists of the business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics)

Geographical Presence

Its geographical footprint covers the USA, India, Russia & CIS nations, China, Brazil, and Europe.

  • Company Secretary,Compliance Officer
    K Randhir Singh
  • Chief Executive Officer
    Erez Israeli
  • Global Head(Biologics)
    Dr. Jayanth Sridhar
  • Chief Executive Officer(North America Generics)
    Marc Kikuchi
  • Chief Information & Digital Officer
    Mukesh Rathi
  • Global Head(Quality,Pharmacology,Vigilance)
    Dr. Ranjana Pathak

FAQs on Dr. Reddy's Laboratories Ltd.

What is the share price of Dr. Reddy's Laboratories Ltd.?

Dr. Reddy's Laboratories Ltd. share price is ₹6,338.75 as of February 21, 2024, 02:38 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Dr. Reddy's Laboratories Ltd.?

The 52-week high and low of Dr. Reddy's Laboratories Ltd. is ₹6,465.00 and ₹4,297.00 respectively as of February 21, 2024, 02:38 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Dr. Reddy's Laboratories Ltd.?

The trailing twelve month (TTM) PB ratio of Dr. Reddy's Laboratories Ltd. is 4.60 as of February 21, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Dr. Reddy's Laboratories Ltd.?

The Upper Circuit of Dr. Reddy's Laboratories Ltd. is ₹7,014. The Lower Circuit of Dr. Reddy's Laboratories Ltd. is ₹5,738.

What is the ROE of Dr. Reddy's Laboratories Ltd.?

Dr. Reddy's Laboratories Ltd. reported an ROE of 19.35% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Dr. Reddy's Laboratories Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Dr. Reddy's Laboratories Ltd., Promoter held 26.6%, the FII held 28.6%, DII held 34% and the public held 10.6% of the total shares.

How to buy Dr. Reddy's Laboratories Ltd. Share?

You can easily buy shares of Dr. Reddy's Laboratories Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Dr. Reddy's Laboratories Ltd.?

The fair value of Dr. Reddy's Laboratories Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer